Product NDC: | 0074-6326 |
Proprietary Name: | Erythromycin Base Filmtab |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 250 mg/1 & nbsp; Erythromycin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-6326 |
Labeler Name: | Abbott Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA061621 |
Marketing Category: | ANDA |
Start Marketing Date: | 19720711 |
Package NDC: | 0074-6326-13 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0074-6326-13) |
NDC Code | 0074-6326-13 |
Proprietary Name | Erythromycin Base Filmtab |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0074-6326-13) |
Product NDC | 0074-6326 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19720711 |
Marketing Category Name | ANDA |
Labeler Name | Abbott Laboratories |
Substance Name | ERYTHROMYCIN |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |